### [2003-10-29](/news/2003/10/29/index.md)

#  The US FDA approves Risperdal Consta (Risperidone long-acting injection) for the treatment of schizophrenia. Although already approved in several other countries, it is the first long-acting, atypical antipsychotic medication to be approved by the FDA.




### Related:

1. [The U.S. Food and Drug Administration announces a ban on the sale of dietary supplement ephedra, citing "an unreasonable risk of illness or injury" from the use of the drug. [http:--www.cnn.com-2003-HEALTH-12-30-ephedra-index.html]](/news/2003/12/30/the-u-s-food-and-drug-administration-announces-a-ban-on-the-sale-of-dietary-supplement-ephedra-citing-an-unreasonable-risk-of-illness-or.md) _Context: Food and Drug Administration, drug_
2. [The Food and Drug Administration has approved the first treatment that genetically engineers patients' own blood cells to destroy acute lymphoblastic leukemia. The approval makes Novartis the proprietor of the first gene therapy to hit the U.S. market. ](/news/2017/08/30/the-food-and-drug-administration-has-approved-the-first-treatment-that-genetically-engineers-patients-own-blood-cells-to-destroy-acute-lymp.md) _Context: Food and Drug Administration_
3. [The U.S. Food and Drug Administration asks pharmaceutical manufacturer Endo International plc to withdraw its long-lasting (12 hours) opioid painkiller, Opana ER, from the market after an FDA panel concluded the drug's benefits no longer outweighed the risks of abuse. Endo is evaluating its options. ](/news/2017/06/8/the-u-s-food-and-drug-administration-asks-pharmaceutical-manufacturer-endo-international-plc-to-withdraw-its-long-lasting-12-hours-opioid.md) _Context: Food and Drug Administration_
4. [The U.S. FDA approves Tesaro's ovarian cancer drug, Niraparib. ](/news/2017/03/27/the-u-s-fda-approves-tesaro-s-ovarian-cancer-drug-niraparib.md) _Context: Food and Drug Administration_
5. [The United States Food and Drug Administration announces it has relaxed its official requirements regarding the use of the abortion drug Mifeprex (RU-486). The current guidelines were based on 1990s medical evidence. Changes include reducing the number of physician visits required by abortion-seeking women, reducing drug dosage, and allowing women to take the drug for three weeks longer -- now a total of 70 days. ](/news/2016/03/30/the-united-states-food-and-drug-administration-announces-it-has-relaxed-its-official-requirements-regarding-the-use-of-the-abortion-drug-mif.md) _Context: Food and Drug Administration_
